Mesoporous SiO 2 based nanocomplex enzymes for enhanced chemodynamic therapy of pancreatic tumors
Nanoscale · 2025
DOI: 10.1039/d4nr02406k ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Yue Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. cai.dingfang@zs-hospital.sh.cn. Hauptthemen laut MEDLINE: Silicon Dioxide, Pancreatic Neoplasms, Genistein, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
The core-shell Gen@mSiO 2 @MnO 2 -PEG nanozymes can serve as an effective platform for ROS-mediated tumor therapy, combining the strengths of CDT and drug therapy in the treatment of pancreatic cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Integrative Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. cai.dingfang@zs-hospital.sh.cn.
- Laboratory of Neurology, Institute of Integrative Medicine, Fudan University, Shanghai, China.
Zitieren
APA
Fan, Y., Yu, S., Yang, Z., & Cai, D. (2025). Mesoporous SiO 2 based nanocomplex enzymes for enhanced chemodynamic therapy of pancreatic tumors. Nanoscale. https://doi.org/10.1039/d4nr02406k
Vancouver
Fan Y, Yu S, Yang Z, Cai D. Mesoporous SiO 2 based nanocomplex enzymes for enhanced chemodynamic therapy of pancreatic tumors. Nanoscale. 2025. doi:10.1039/d4nr02406k
BibTeX
@article{Fan2025,
author = {Fan, Yue and Yu, Shulin and Yang, Zhaoshuo and Cai, Dingfang},
title = {Mesoporous SiO 2 based nanocomplex enzymes for enhanced chemodynamic therapy of pancreatic tumors},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr02406k}
}
EUVIMED